Structural analysis and intelligent classification of clinical trial eligibility criteria based on deep learning and medical text mining
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces Clinical Trial Eligibility Criteria Automatic Classification (CTEC-AC) to structure clinical trial criteria. The model automates classification, improving trial efficiency and participant recruitment.
Area Of Science
- Biomedical Informatics
- Clinical Trial Management
- Natural Language Processing
Background
- Clinical trial efficiency, quality, and innovation are paramount.
- Structuring eligibility criteria is crucial for effective trial management.
- Current methods for handling eligibility criteria are often manual and time-consuming.
Purpose Of The Study
- To introduce a novel model, CTEC-AC, for automatic classification of clinical trial eligibility criteria.
- To structure eligibility criteria into computationally explainable classifications.
- To enhance the efficiency, quality, and innovation capability of clinical trials.
Main Methods
- Utilized 2,500 clinical trials from ClinicalTrials.gov, generating over 20,000 eligibility criteria entries.
- Integrated ClinicalBERT and MetaMap for enhanced feature representation of criteria.
- Employed hierarchical clustering and expert validation for automated classification.
Main Results
- Identified 31 distinct categories summarizing clinical trial eligibility criteria.
- Uncovered common themes in the expression of eligibility criteria.
- Achieved a macro-average F1 score of 0.94 using the automated classification model.
Conclusions
- The CTEC-AC model automatically extracts structured representations from unstructured eligibility criteria text.
- This advancement significantly enhances the informatization of clinical trials.
- The model improves the intelligence of automated participant recruitment for researchers.
Related Concept Videos
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

